The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of BRAF inhibitor (BRAFi) encorafenib (ENCO) plus MEK inhibitor (MEKi) binimetinib (BINI) in cutaneous melanoma patients naive to BRAFi treatment.
 
Ryan J. Sullivan
Consulting or Advisory Role - Astex Pharmaceuticals
 
Jeffrey S. Weber
Stock and Other Ownership Interests - Altor BioScience; Celldex; Merck
Honoraria - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Consulting or Advisory Role - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Genentech; GlaxoSmithKline; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
 
Sapna Pradyuman Patel
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; MD Anderson Cancer Center
Speakers' Bureau - Merck; Prometheus
Research Funding - Bristol-Myers Squibb; Deciphera; GlaxoSmithKline; Novartis; Prometheus; Reata Pharmaceuticals
 
Reinhard Dummer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
 
Wilson H. Miller
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche Pharma AG
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
David Cosgrove
Employment - BTG; Therapure
Honoraria - BTG
Consulting or Advisory Role - Therapure
Travel, Accommodations, Expenses - BTG; Therapure
 
Matteo S. Carlino
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
 
Daniel Shao-Weng Tan
Consulting or Advisory Role - Boehringer Ingelheim; Novartis
Research Funding - Novartis
 
Celeste Lebbe
Honoraria - Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis
Travel, Accommodations, Expenses - Roche
 
Tiziana Cipani
No Relationships to Disclose
 
Elena Élez
No Relationships to Disclose
 
Heiko Maacke
Employment - Novartis
 
Panagiotis Nikolopoulos
Employment - Novartis
 
Mounir Aout
Employment - Novartis
Other Relationship - Novartis
 
Laure A. De Parseval
Employment - Novartis
Stock and Other Ownership Interests - Celgene; Novartis
 
Paolo Antonio Ascierto
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche/Genentech; Ventana Medical Systems
Research Funding - Bristol-Myers Squibb (Inst); Roche/Genentech (Inst); Ventana Medical Systems (Inst)